Patent ID: 11944837
Assignee: ASHA MEDICAL, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 1:
2. The system of claim 1, wherein the AP magnetic field is further adapted to modify a cancer microenvironment (TME) surrounding the cancer cells by at least one of:
increasing a number of CD8+ lymphocytes in the TME surrounding the cancer cells;
increasing a ratio of CD8+ to total lymphocytes in the TME surrounding the cancer cells;
increasing a number of CD4+ lymphocytes surrounding the cancer cells;
increasing a ratio of CD4+ to total lymphocytes in the TME surrounding the cancer cells;
increasing a number of tumor infiltrating lymphocytes (TILs) in the TME surrounding the cancer cells;
increasing a number of antigen presenting cells (APCs) in the TME surrounding the cancer cells;
increasing a concentration of tumor-suppressive cytokines in the TME surrounding the cancer cells;
decreasing a concentration of tumor-promoting cytokines in the TME surrounding the cancer cells; and
increasing one of a number or a concentration of natural killer (NK) cells in the TME surrounding the cancer cells.